专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明授权

US5677426A Anti-IL-8 antibody fragments 失效
标题翻译：抗IL-8抗体片段
公开(公告)号：US5677426A
公开(公告)日：1997-10-14
申请号：US398613
申请日：1995-03-01
申请人： Sherman Fong , Caroline Alice Hebert , Kyung Jin Kim , Steven R. Leong
发明人： Sherman Fong , Caroline Alice Hebert , Kyung Jin Kim , Steven R. Leong
IPC分类号： C12N15/02 , A61K38/00 , A61K39/395 , A61P29/00 , C07H21/04 , C07K16/24 , C12N15/09 , C12P21/08 , C07K16/00
CPC分类号： C07K16/244 , A61K38/00 , C07K2317/24 , C07K2319/00
摘要： Anti-IL-8 monoclonal antibodies are described for use in diagnostic applications and in the treatment of inflammatory disorders such as inflammatory bowel disease and bacteria pneumonias.
摘要翻译：描述了抗IL-8单克隆抗体用于诊断应用和治疗炎症性疾病如炎症性肠病和细菌性肺炎。

22. 发明授权

US09581748B2 Optical member and display device including the same 有权
标题翻译：光学构件和包括其的显示装置
公开(公告)号：US09581748B2
公开(公告)日：2017-02-28
申请号：US13982916
申请日：2011-11-30
申请人： Soon Young Hyun , June Roh , Kyung Jin Kim , Ja Ram Kim , Jae Hong Lee
发明人： Soon Young Hyun , June Roh , Kyung Jin Kim , Ja Ram Kim , Jae Hong Lee
IPC分类号： F21V7/04 , F21V8/00 , G02F1/1335 , F21V9/00
CPC分类号： G02B6/0026 , F21V9/00 , G02B6/0003 , G02B6/0011 , G02B6/0068 , G02B6/0073 , G02F1/1336 , G02F1/133615 , G02F2001/133614 , G02F2202/36
摘要： Disclosed are an optical member and a display device including the same. The optical member includes a receiving member; a host in the receiving member; and a plurality of wavelength conversion particles distributed in the host. The receiving member includes a light incident part having a first refractive index; and a light exit part having a second refractive index different from the first refractive index. The optical member improves the optical characteristics by adjusting the refractive indexes of the light incident part and the light exit part.
摘要翻译：公开了一种光学构件和包括该构件的显示装置。光学构件包括接收构件; 接收成员中的主机; 以及分散在主机中的多个波长转换粒子。接收构件包括具有第一折射率的光入射部分; 以及具有与第一折射率不同的第二折射率的光出射部。光学构件通过调节光入射部分和光出射部分的折射率来提高光学特性。

23. 发明申请

US20110287024A1 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 审中-公开
标题翻译：血管内皮细胞生长因子拮抗剂
公开(公告)号：US20110287024A1
公开(公告)日：2011-11-24
申请号：US13053164
申请日：2011-03-21
申请人： Napoleone Ferrara , Kyung Jin Kim
发明人： Napoleone Ferrara , Kyung Jin Kim
IPC分类号： A61K39/395 , A61P27/02 , A61K38/17
CPC分类号： C07K16/22 , A61K38/179 , A61K38/1866 , A61K2039/505 , C07K14/475 , C07K16/2863 , C07K2317/73 , C07K2317/76 , C07K2319/30
摘要： The present invention provides human vascular endothelial cell growth factor (hVEGF) antagonists, including monoclonal antibodies, hVEGF receptors, and hVEGF variants that are useful for the treatment of age-related macular degeneration, and other diseases and disorders characterized by undesirable or excessive neovascularization.
摘要翻译：本发明提供了人类血管内皮细胞生长因子（hVEGF）拮抗剂，包括可用于治疗年龄相关性黄斑变性的单克隆抗体，hVEGF受体和hVEGF变体以及以不良或过度新生血管形成为特征的其它疾病和病症。

24. 发明申请

US20100273257A1 Apo-2DcR 审中-公开
公开(公告)号：US20100273257A1
公开(公告)日：2010-10-28
申请号：US12321115
申请日：2009-01-15
申请人： Avi J. Ashkenazi , Kevin P. Baker , Anan Chuntharapai , Austin Gurney , Kyung Jin Kim , William I. Wood
发明人： Avi J. Ashkenazi , Kevin P. Baker , Anan Chuntharapai , Austin Gurney , Kyung Jin Kim , William I. Wood
IPC分类号： C12N5/10 , C07K14/00 , C07K16/18 , C12N5/16 , C07H21/04 , C12N15/63 , C12N1/19 , C12N1/21 , C12N5/071
CPC分类号： C07K14/47 , A01K2217/05 , A61K38/00 , A61K2039/505 , C07K14/4747 , C07K14/70578 , C07K16/2878 , C07K2319/00 , G01N33/57484 , G01N33/68
摘要： Novel polypeptides, designated Apo-2DcR, which are capable of binding Apo-2 ligand are provided. Compositions including Apo-2DcR chimeras, nucleic acid encoding Apo-2DcR, and antibodies to Apo-2DcR are also provided.
摘要翻译：提供了能够结合Apo-2配体的新型多肽，称为Apo-2DcR。还提供了包含Apo-2DcR嵌合体，编码Apo-2DcR的核酸和Apo-2DcR抗体的组合物。

25. 发明申请

US20100221250A1 METHODS OF TREATING BRAIN TUMORS WITH ANTIBODIES 审中-公开
标题翻译：用抗体治疗脑肿瘤的方法
公开(公告)号：US20100221250A1
公开(公告)日：2010-09-02
申请号：US12690045
申请日：2010-01-19
申请人： Kyung Jin Kim , John Laterra , Bachchu Lal
发明人： Kyung Jin Kim , John Laterra , Bachchu Lal
IPC分类号： A61K39/395 , A61P35/00
CPC分类号： C07K16/22 , A61K2039/505 , C07K16/3053 , C07K2317/73 , C07K2317/76
摘要： The application is directed toward a method of treating a brain tumor in a patient comprising systemically administering a monoclonal antibody.
摘要翻译：本申请涉及治疗患者的脑肿瘤的方法，其包括全身施用单克隆抗体。

26. 发明申请

US20100119523A1 VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS 审中-公开
公开(公告)号：US20100119523A1
公开(公告)日：2010-05-13
申请号：US12573720
申请日：2009-10-05
申请人： Napoleone Ferrara , Kyung Jin Kim
发明人： Napoleone Ferrara , Kyung Jin Kim
IPC分类号： A61K39/395 , A61P27/02
CPC分类号： C07K16/22 , A61K38/179 , A61K38/1866 , A61K2039/505 , C07K14/475 , C07K16/2863 , C07K2317/73 , C07K2317/76 , C07K2319/30
摘要： The present invention provides human vascular endothelial cell growth factor (hVEGF) antagonists, including monoclonal antibodies, hVEGF receptors, and hVEGF variants that are useful for the treatment of age-related macular degeneration, and other diseases and disorders characterized by undesirable or excessive neovascularization.

27. 发明申请

US20100075637A1 MOBILE TERMINAL AND COMMUNICATION HISTORY PROVIDING METHOD USING THE SAME 有权
标题翻译：移动终端和通信历史提供方法
公开(公告)号：US20100075637A1
公开(公告)日：2010-03-25
申请号：US12427235
申请日：2009-04-21
申请人： Kyung Jin Kim , Jee Young Chun , Sae Kyu Park , Yong Man Park , Ji Hyun Kim
发明人： Kyung Jin Kim , Jee Young Chun , Sae Kyu Park , Yong Man Park , Ji Hyun Kim
IPC分类号： H04L12/58
CPC分类号： H04L51/34 , H04L51/38
摘要： A mobile terminal including a communication unit configured to provide a communication function including at least one of an outgoing communication function and an incoming communication function, a controller configured to acquire surrounding data including at least one of image data or sound data corresponding to a surrounding of where the communication function is performed, and to match the acquired surrounding data with communication information indicating a first party of the outgoing function or a second party of the incoming communication function, and a display unit configured to display a communication history including the communication information matched with the surrounding data. In addition, the controller is further configured to acquire the surrounding data selectively based on a) a manual operation of the terminal or b) automatically without user intervention.
摘要翻译：一种移动终端，包括：通信单元，被配置为提供包括传出通信功能和传入通信功能中的至少一个的通信功能;控制器，被配置为获取周围数据，所述控制器被配置为获取包括与周围环境对应的图像数据或声音数据中的至少一个其中执行通信功能，并且将获取的周围数据与指示出站功能的第一方的通信信息或进入通信功能的第二方匹配;以及显示单元，被配置为显示包括匹配的通信信息的通信历史与周围的数据。此外，控制器还被配置为基于a）终端的手动操作或b）自动地获取周围数据而无需用户干预。

28. 发明申请

US20090081232A1 METHODS OF TREATING DISEASES WITH ANTI-VEGF ANTIBODIES 审中-公开
标题翻译：用抗VEGF抗体治疗疾病的方法
公开(公告)号：US20090081232A1
公开(公告)日：2009-03-26
申请号：US12329428
申请日：2008-12-05
申请人： Kyung Jin Kim
发明人： Kyung Jin Kim
IPC分类号： A61K39/395 , A61P35/00
CPC分类号： C07K16/22 , A61K38/00 , A61K47/6425 , A61K47/6811 , A61K47/6843 , A61K2039/505 , C07K14/52 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/30
摘要： The present invention provides monoclonal antibodies, and portions thereof, which are capable of specifically binding to human vascular endothelial cell growth factor (hVEGF) or hVEGF-related protein. The invention also provides hybridoma cell lines that produce such monoclonal antibodies. The monoclonal antibodies of the invention are useful as therapeutic agents either by themselves or in conjunction with cytotoxic or other chemotherapeutic agents, to treat diseases that are characterized by excessive vascular endothelial cell proliferation. The monoclonal antibodies of the invention also are useful in diagnostic and analytical methods for determining the presence of hVEGF or hVEGF related-protein in a test sample.
摘要翻译：本发明提供能够特异性结合人血管内皮细胞生长因子（hVEGF）或hVEGF相关蛋白的单克隆抗体及其部分。本发明还提供了产生这种单克隆抗体的杂交瘤细胞系。本发明的单克隆抗体本身或与细胞毒性或其它化学治疗剂联用可用作治疗剂，以治疗以过量血管内皮细胞增殖为特征的疾病。本发明的单克隆抗体也可用于测定样品中hVEGF或hVEGF相关蛋白的存在的诊断和分析方法。

29. 发明申请

US20080233646A1 Human DR4 antibodies and uses thereof 有权
标题翻译：人DR4抗体及其用途
公开(公告)号：US20080233646A1
公开(公告)日：2008-09-25
申请号：US11819575
申请日：2007-06-28
申请人： Anan Chuntharapai , Kyung Jin Kim
发明人： Anan Chuntharapai , Kyung Jin Kim
IPC分类号： C12N5/06
CPC分类号： C07K16/2878 , A61K2039/505 , C07K2317/21 , C07K2317/73 , C07K2317/75 , C07K2317/76 , C07K2319/30 , G01N2510/00
摘要： Human Death Receptor 4 (DR4) antibodies are provided. The human DR4 antibodies may be included in pharmaceutical compositions, articles of manufacture, or kits. Methods of treatment and diagnosis using the DR4 antibodies are also provided.
摘要翻译：提供人类死亡受体4（DR4）抗体。人类DR4抗体可以包括在药物组合物，制品或试剂盒中。还提供了使用DR4抗体的治疗和诊断方法。

30. 发明授权

US06713609B1 Monoclonal antibodies to type I interferon receptor 失效
标题翻译： I型干扰素受体的单克隆抗体
公开(公告)号：US06713609B1
公开(公告)日：2004-03-30
申请号：US09056461
申请日：1998-04-07
申请人： Anan Chuntharapai , Kyung Jin Kim , Richard B. Love , Ji Lu
发明人： Anan Chuntharapai , Kyung Jin Kim , Richard B. Love , Ji Lu
IPC分类号： C07K1628
CPC分类号： G01N33/6866 , C07K16/2866 , C07K2317/76 , C07K2317/92 , C07K2319/30 , G01N2333/56
摘要： Anti-IFNAR1 monoclonal antibodies with neutralizing activities against the anti-viral cytopathic effects of various type I interferons are provided.
摘要翻译：提供具有针对各种I型干扰素的抗病毒细胞病变作用的中和活性的抗IFNAR1单克隆抗体。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式